BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 19211248)

  • 41. Potent antitubulin tumor cell cytotoxins based on 3-aroyl indazoles.
    Duan JX; Cai X; Meng F; Lan L; Hart C; Matteucci M
    J Med Chem; 2007 Mar; 50(5):1001-6. PubMed ID: 17286393
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis and Biological Evaluation of 3-Alkyl-1,5-Diaryl-1H-Pyrazoles as Rigid Analogues of Combretastatin A-4 with Potent Antiproliferative Activity.
    Xu Q; Qi H; Sun M; Zuo D; Jiang X; Wen Z; Wang Z; Wu Y; Zhang W
    PLoS One; 2015; 10(6):e0128710. PubMed ID: 26061410
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Solution-phase parallel synthesis and biological evaluation of combretatriazoles.
    Cafici L; Pirali T; Condorelli F; Del Grosso E; Massarotti A; Sorba G; Canonico PL; Tron GC; Genazzani AA
    J Comb Chem; 2008; 10(5):732-40. PubMed ID: 18681482
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis and antiproliferative effects of 5,6-disubstituted Pyridazin-3(2H)-ones designed as conformationally constrained combretastatin A-4 Analogues.
    Elagawany M; Schmitt M; Ghiaty A; El-Etrawy ASh; Ibrahim MA; Bihel F; Sbardelotto AB; Pessoa C; Nguyen TL; Hamel E; Bourguignon JJ
    Anticancer Agents Med Chem; 2013 Sep; 13(7):1133-40. PubMed ID: 23574386
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 1,2,3,4-tetrahydro-2-thioxopyrimidine analogs of combretastatin-A4.
    Lee L; Davis R; Vanderham J; Hills P; Mackay H; Brown T; Mooberry SL; Lee M
    Eur J Med Chem; 2008 Sep; 43(9):2011-5. PubMed ID: 18226429
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Palladium-Catalyzed One-Pot Reaction of Hydrazones, Dihaloarenes, and Organoboron Reagents: Synthesis and Cytotoxic Activity of 1,1-Diarylethylene Derivatives.
    Roche M; Salim SM; Bignon J; Levaique H; Brion JD; Alami M; Hamze A
    J Org Chem; 2015 Jul; 80(13):6715-27. PubMed ID: 26036279
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structural determinants of resveratrol for cell proliferation inhibition potency: experimental and docking studies of new analogs.
    Mazué F; Colin D; Gobbo J; Wegner M; Rescifina A; Spatafora C; Fasseur D; Delmas D; Meunier P; Tringali C; Latruffe N
    Eur J Med Chem; 2010 Jul; 45(7):2972-80. PubMed ID: 20395019
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis and biological evaluation of novel heterocyclic derivatives of combretastatin A-4.
    Nguyen TT; Lomberget T; Tran NC; Colomb E; Nachtergaele L; Thoret S; Dubois J; Guillaume J; Abdayem R; Haftek M; Barret R
    Bioorg Med Chem Lett; 2012 Dec; 22(23):7227-31. PubMed ID: 23063401
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis and SAR of 1,3-disubstituted cyclohexylmethyl urea and amide derivatives as non-peptidic motilin receptor antagonists.
    Johnson SG; Gunnet JW; Moore JB; Miller W; Wines P; Rivero RA; Combs D; Demarest KT
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3362-6. PubMed ID: 16650762
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The first total synthesis of natural grenadamide.
    Avery TD; Culbert JA; Taylor DK
    Org Biomol Chem; 2006 Jan; 4(2):323-30. PubMed ID: 16391775
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A novel chiral sulfonium yilde: highly enantioselective synthesis of vinylcyclopropanes.
    Ye S; Huang ZZ; Xia CA; Tang Y; Dai LX
    J Am Chem Soc; 2002 Mar; 124(11):2432-3. PubMed ID: 11890780
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Analogs of the dihydroceramide desaturase inhibitor GT11 modified at the amide function: synthesis and biological activities.
    Bedia C; Triola G; Casas J; Llebaria A; Fabriàs G
    Org Biomol Chem; 2005 Oct; 3(20):3707-12. PubMed ID: 16211106
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis, modelling, and antimitotic properties of tricyclic systems characterised by a 2-(5-Phenyl-1H-pyrrol-3-yl)-1,3,4-oxadiazole moiety.
    Pinna GA; Murineddu G; Murruzzu C; Zuco V; Zunino F; Cappelletti G; Artali R; Cignarella G; Solano L; Villa S
    ChemMedChem; 2009 Jun; 4(6):998-1009. PubMed ID: 19291736
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The impact of cyclopropane configuration on the biological activity of cyclopropyl-epothilones.
    Gaugaz FZ; Redondo-Horcajo M; Barasoain I; Díaz JF; Cobos-Correa A; Kaufmann M; Altmann KH
    ChemMedChem; 2014 Oct; 9(10):2227-32. PubMed ID: 25045073
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Generation of ligand-based pharmacophore model and virtual screening for identification of novel tubulin inhibitors with potent anticancer activity.
    Chiang YK; Kuo CC; Wu YS; Chen CT; Coumar MS; Wu JS; Hsieh HP; Chang CY; Jseng HY; Wu MH; Leou JS; Song JS; Chang JY; Lyu PC; Chao YS; Wu SY
    J Med Chem; 2009 Jul; 52(14):4221-33. PubMed ID: 19507860
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficient synthesis of protected cyclopropyl beta-aspartylphosphates.
    Adams LA; Charmant JP; Cox RJ; Walter M; Whittingham WG
    Org Biomol Chem; 2004 Feb; 2(4):542-53. PubMed ID: 14770233
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Relationship between the structure and antibacterial activity of aryl-thionamides. VI. Synthesis and in vitro tuberculostatic activity of 2-alkylthio-benzothiamides and 2-alkylthio-phenyl-vinylethionamides].
    Tornetta B; Guerrera F; Mazzarino C
    Boll Chim Farm; 1973 Dec; 112(12):832-8. PubMed ID: 4793301
    [No Abstract]   [Full Text] [Related]  

  • 58. Novel CADD-based peptidyl vinyl ester derivatives as potential proteasome inhibitors.
    Mou K; Xu B; Ma C; Yang X; Zou X; Lü Y; Xu P
    Bioorg Med Chem Lett; 2008 Mar; 18(6):2198-202. PubMed ID: 18280155
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis and biological evaluation of 3,4-diaryl-5-aminoisoxazole derivatives.
    Liu T; Dong X; Xue N; Wu R; He Q; Yang B; Hu Y
    Bioorg Med Chem; 2009 Sep; 17(17):6279-85. PubMed ID: 19665898
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis and cytotoxic activity of certain trisubstituted azetidin-2-one derivatives as a cis-restricted combretastatin A-4 analogues.
    Elmeligie S; Taher AT; Khalil NA; El-Said AH
    Arch Pharm Res; 2017 Jan; 40(1):13-24. PubMed ID: 27747473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.